FAQ: Understanding the Rapid Spread of 'Nightmare Bacteria'
Summary
The content discusses the alarming increase in 'nightmare bacteria' cases in the U.S., characterized by antibiotic resistance, high mortality, and ability to spread resistance to other bacteria. This growing crisis has prompted scientific research and corporate efforts to develop treatments.
What are ’nightmare bacteria'?
Nightmare bacteria are a category of bacteria characterized by three deadly attributes: resistance to all or almost all antibiotics, high mortality levels, and their ability to spread antibiotic resistance to other types of bacteria.
Why are these bacteria called ’nightmare bacteria'?
They are called ’nightmare bacteria’ due to their triple threat of being resistant to most antibiotics, having high mortality rates, and being able to spread antibiotic resistance to other bacteria, making them extremely dangerous.
Where is the spread of nightmare bacteria occurring?
Data shows that cases of these bacteria are increasing at an alarming rate in the U.S.
When was the threat of nightmare bacteria first highlighted?
In 2013, former CDC director Tom Frieden observed that there were rising cases of ’nightmare bacteria'.
Who is working on treatments for nightmare bacteria?
For-profit companies like Soligenix Inc. (NASDAQ: SNGX) are focused on developing treatments indicated for these bacteria.
What is the significance of this growing crisis?
The rapid spread of nightmare bacteria represents a serious public health threat due to their antibiotic resistance and high mortality, requiring urgent scientific and medical attention to address the crisis.
Where can I find more information about this topic?
You can Read More» about this topic or visit BioMedWire for more information on biomedical developments.
What is BioMedWire and what role does it play?
BioMedWire is a specialized communications platform focusing on Biotechnology, Biomedical Sciences and Life Sciences sectors, providing breaking news and insightful content about developments like the nightmare bacteria crisis.
This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)
Article Control ID: 241544